Hyoscine Butylbromide

Palliative Care

Palliative Care · Antimuscarinic antispasmodic

Hyoscine Butylbromide

Dose

20 mg SC/IV up to QDS; 60–120 mg/24 h via syringe driver for respiratory secretions.

Use

Bowel colic, inoperable bowel obstruction, death rattle.

Monitoring

Secretion volume, bowel sounds, urinary retention.

Side effects

  • Dry mouth
  • Urinary retention
  • Tachycardia

Related in WardRound

Always confirm dose against your local formulary / BNF before prescribing.

WardRound

WardRound

Clinical Decisions in Seconds